
Sign up to save your podcasts
Or
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
7,688 Listeners
415 Listeners
32,040 Listeners
110,847 Listeners
55,848 Listeners
21 Listeners
26 Listeners
111 Listeners
12,474 Listeners
15,321 Listeners
10,249 Listeners
68 Listeners
25 Listeners
4 Listeners
38 Listeners